Created from the research activities of Solvay SA on food ingredients and digestive health, based on renewable materials and chemistry, Group Solactis SAS is a biotech company focused on nutritional innovations dedicated to specific research partnerships with food groups, academic laboratories, as well as with other biotech firms in targeted health nutritional areas such as digestive health, transit regulation and immunity.
Groupe Solactis will draw on its expertise in the field of intestinal flora and prebiotic actions to offer solutions throughout the entire new food product development cycle, from the identification of new targeted health benefits up to the discovery of new end-products.
In order to achieve its objectives, Groupe Solactis now has at its disposal the dossiers that enabled it to obtain health claims on prebiotic (South Korea) and transit (Europe Union) for galactofructose (or lactulose), application patents, unique dry forms specially adapted to the food industry, clinical studies and numerous tests in diversified food matrices. For its promotion, Groupe Solactis will be able to build on the growing awareness of its Solactis brand for human nutrition, and Vitaloa brand for animal feed.
Pascal Ronfard, founder and president of Groupe Solactis, said: “Groupe Solactis will capitalise on the human nutrition and animal feed rapidly growing markets, to implement significant partnerships and contracts with food and feed groups, in its areas of specialisation: digestive health, transit regulation and immunity. Through this MBO, Groupe Solactis has acquired all the necessary assets to become a new player in human nutrition and animal feed.”
Source: Groupe Solactis SAS
© FoodBev Media Ltd 2024